XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Paid-In Capital
Retained Earnings
Unearned ESOP Shares
Accumulated Other Comprehensive Loss
Balance at beginning of period (in shares) at Jun. 30, 2023   65,864,000        
Balance at beginning of period at Jun. 30, 2023 $ 869,284 $ 659 $ 503,332 $ 457,611 $ (22,862) $ (69,456)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net Income 3,412     3,412    
Other comprehensive loss, net of income tax 5,797         5,797
ESOP shares committed to be released 1,123   (337)   1,460  
Stock repurchases (in shares)   (1,505,000)        
Stock repurchases (11,240) $ (15) (11,225)      
Issuance of stock under stock benefit plans (in shares)   133,000        
Issuance of stock under stock benefit plan 0 $ 1 (1)      
Stock-based compensation expense 1,887   1,887      
Cancellation of shares issued for restricted stock awards (in shares)   (55,000)        
Cancellation of shares issued for restricted stock awards (470) $ (1) (469)      
Cash dividends declared (20,715)     (20,715)    
Balance at end of period (in shares) at Mar. 31, 2024   64,437,000        
Balance at end of period at Mar. 31, 2024 849,078 $ 644 493,187 440,308 (21,402) (63,659)
Balance at beginning of period (in shares) at Dec. 31, 2023   64,445,000        
Balance at beginning of period at Dec. 31, 2023 847,978 $ 645 493,297 439,755 (21,889) (63,830)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net Income 7,397     7,397    
Other comprehensive loss, net of income tax 171         171
ESOP shares committed to be released 352   (135)   487  
Stock-based compensation expense 95   95      
Cancellation of shares issued for restricted stock awards (in shares)   (8,000)        
Cancellation of shares issued for restricted stock awards (71) $ (1) (70)      
Cash dividends declared (6,844)     (6,844)    
Balance at end of period (in shares) at Mar. 31, 2024   64,437,000        
Balance at end of period at Mar. 31, 2024 $ 849,078 $ 644 493,187 440,308 (21,402) (63,659)
Balance at beginning of period (in shares) at Jun. 30, 2024 64,434,424 64,434,000        
Balance at beginning of period at Jun. 30, 2024 $ 753,571 $ 644 493,680 343,326 (20,916) (63,163)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net Income 19,306     19,306    
Other comprehensive loss, net of income tax (5,965)         (5,965)
ESOP shares committed to be released 1,052   (407)   1,459  
Issuance of stock under stock benefit plans (in shares)   207,000        
Issuance of stock under stock benefit plan 0 $ 2 (2)      
Stock-based compensation expense 1,209   1,209      
Cancellation of shares issued for restricted stock awards (in shares)   (61,000)        
Cancellation of shares issued for restricted stock awards (349)   (349)      
Cash dividends declared $ (20,711)     (20,711)    
Balance at end of period (in shares) at Mar. 31, 2025 64,579,683 64,580,000        
Balance at end of period at Mar. 31, 2025 $ 748,113 $ 646 494,131 341,921 (19,457) (69,128)
Balance at beginning of period (in shares) at Dec. 31, 2024   64,580,000        
Balance at beginning of period at Dec. 31, 2024 744,853 $ 646 494,092 342,155 (19,943) (72,097)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net Income 6,648     6,648    
Other comprehensive loss, net of income tax 2,969         2,969
ESOP shares committed to be released 343   (143)   486  
Stock-based compensation expense 182   182      
Cash dividends declared $ (6,882)     (6,882)    
Balance at end of period (in shares) at Mar. 31, 2025 64,579,683 64,580,000        
Balance at end of period at Mar. 31, 2025 $ 748,113 $ 646 $ 494,131 $ 341,921 $ (19,457) $ (69,128)